American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6410)
  2. Solid Tumor Oncology Division (5548)
  3. Survivorship Research (1999)
  4. Genitourinary Oncology Service (1769)
  5. Surgery (1639)
  6. Epidemiology and Biostatistics (1496)
  7. GSK Faculty (1390)
  8. Population Sciences Research Program (1380)
  9. Gastrointestinal Oncology Service (1357)
  10. Hematologic Malignancies, Division of (1286)
Search Within
Formats
  1. Meeting Abstract (6344)
  2. Journal Article (2587)
  3. Editorial (78)
  4. Review (69)
  5. Guidelines (55)
  6. Correspondence (49)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6410)
  2. Solid Tumor Oncology Division (5548)
  3. Survivorship Research (1999)
  4. Genitourinary Oncology Service (1769)
  5. Surgery (1639)
  6. Epidemiology and Biostatistics (1496)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (308)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (297)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8709)
  2. JCO Precision Oncology (172)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (53)
  6. JCO Oncology Practice (12)

More Publications

Results (9189)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Event-free survival (EFS) in MATTERHORN: A randomized, phase 3 study of durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel chemotherapy (FLOT) in resectable gastric/gastroesophageal junction cancer (GC/GEJC)
    Meeting Abstract

    Janjigian, Y. Y.; Al-Batran, S. E.; Wainberg, Z. A.; Muro, K.; Molena, D.; Van Cutsem, E.; Hyung, W. J.; Wyrwicz, L.; Oh, D.; Omori, T.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • TBCRC 058: A randomized phase II study of enzalutamide, enzalutamide with mifepristone, and treatment of physician's choice in patients with androgen receptor-positive metastatic triple-negative or estrogen receptor-low breast cancer (NCT06099769)
    Meeting Abstract

    Traina, T. A.; Chen, Y.; Khoury, K.; Rugo, H. S.; Mayer, E. L.; Abdou, Y.; Melisko, M. E.; Pareja, F.; Weigelt, B.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer (HERO): NRG-BR008
    Meeting Abstract

    Braunstein, L. Z.; Mitchell, M.; Bandos, H.; Sikov, W. M.; Khan, A. J.; Chen, P. Y.; Ganz, P. A.; Jagsi, R.; White, J. R.; Cecchini, R. S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Diversity and representation in head and neck cancer trials following the 2010 Affordable Care Act
    Meeting Abstract

    Borkhetaria, P.; Lee, N. Y.; Kang, J. J.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Emiltatug ledadotin (Emi-Le): A B7-H4-directed dolasynthen antibody-drug conjugate (ADC) being investigated in phase 1 dose expansion in patients with triple negative breast cancer who received at least one prior topoisomarase-1 inhibitor ADC
    Meeting Abstract

    Han, H. S.; Kalinsky, K.; Abuhadra, N.; Giordano, A.; Starks, D.; Wulf, G. M.; McAndrew, N. P.; O'Shaughnessy, J.; Spira, A. I.; Chan, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Insurance disparities among subgroups of Hispanic Americans with cancer
    Meeting Abstract

    Nguyen, I.; Nguyen, L.; Feng, E.; Feng, E. L. L.; Feliciano, E.; Dee, E. C.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Trends in location of death among adolescents and young adults with solid and liquid tumors in the United States
    Meeting Abstract

    Ashar, P.; Jain, U.; Tudisco, A.; Willmann, J.; Feliciano, E. J. G.; Wolden, S. L.; Gomez, D. R.; Iyengar, P.; Dee, E. C.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Trajectories of clinical encounters among long-term lung cancer survivors: A SEER-Medicare cluster analysis
    Meeting Abstract

    Zhang, Y.; Zhang, H.; Rosa, W. E.; Bao, Y.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Early insights into the impact of an ambient AI scribe solution on clinical documentation to reduce clinician burnout in oncology
    Meeting Abstract

    Baldwin, A.; Lipitz-Snyderman, A.; Goyal, S.; Kuperman, G.; Stetson, P. D.; Chimonas, S.; Watson, A.; Damstrom, M.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Addressing clinical trial barriers in lung cancer: Patient-reported impact of resources on trial participation
    Meeting Abstract

    Preeshagul, I. R.; Das, D. G.; Arfe, A.; Awad, M. M.; Feldman, J. L.; Conneran, T.; Horn, M. K.; Singhi, E. K.; Daly, R. M.; Wozniak, A. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save